Fimasartan oxine B Br J Pharmacol

Br J Pharmacol

17-pentaazacycloicosane-4-carboxamide acetate

InChiKey: AUIHHZBJBKRDIE-UHFFFAOYSA-N

3-b]indole

EHop-016 also inhibits the Rac activity of MDA-MB-231 metastatic breast cancer cells and reduces Rac-directed lamellipodia formation in both cell lines

Fimasartan oxine B Br J PharmacolFimasartan is a non peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure. Through oral administration, fimasartan blocks angiotensin II receptor type 1 (AT1 receptors), reducing pro hypertensive actions of angiotensin II, such as systemic vasoconstriction and water retention by the kidneys. Fimasartan was approved for use in South Korea in September 9th, 2010. Product information CAS Number: 247257